3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
13
cyclopia sequence
7
Neoplasms
6
Multiple Myeloma
6
Fatigue
6
Neoplasms, Plasma Cell
5
Neoplasm Metastasis
4
Lung Neoplasms
4
Dyspnea
4
Carcinoma, Non-Small-Cell Lung
4
Anxiety Disorders
4
Uterine Cervical Neoplasms
3
Tobacco Use Cessation
3
Prostatic Neoplasms
3
Primary Myelofibrosis
3
Leukemia
3
Head and Neck Neoplasms
3
Depression
3
Carcinoma, Renal Cell
3
Vomiting
2
Smoking Cessation
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Parasomnias
2
Pancreatic Neoplasms
2
Pain
2
Osteosarcoma
2
Kidney Neoplasms
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Interventions
pazopanib
5
Doxorubicin
3
Bevacizumab
3
carotuximab
2
Sorafenib
2
Radiotherapy, Conformal
2
Paclitaxel
2
Gemcitabine
2
tremelimumab
1
trebananib
1
temsirolimus
1
talimogene laherparepvec
1
romidepsin
1
regorafenib
1
indolepropanol phosphate
1
eribulin
1
durvalumab
1
cixutumumab
1
Watchful Waiting
1
Vascular Endothelial Growth Factor A
1
TTI-621
1
Sunitinib
1
Sirolimus
1
Razoxane
1
Observation
1
Magnetic Resonance Spectroscopy
1
Ifosfamide
1
HhAntag691
1
Fluorodeoxyglucose F18
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hemangiosarcoma
×
Surveys and Questionnaires
×
Clear all
No trials found.